Connect with us

Cannabis News

Medical Marijuana ‘Significantly’ Decreases Use Of Opioids By Chronic Pain Patients, New Study Finds

Published

9 months ago

on

A new study shows that marijuana pain can be an effective replacement for the treatment of pain management.

Murdoch University researchers and research centers in Perth Pain Management Center to investigate how people who have been treating people with chronic cancer cancer pain.

Research published in Pain Management on Monday, “Cannabinoid co-prescriptions may be able to reduce the consumption prescribed for the chronic consumption of the pain kingdom.”

To assess the relationship between cannabis and opioids, the researchers followed two patients in a year: they were already in pain in the pain clinic and a Cannabis co-patient and another 53 patients, without Marijuanik, in a clinic.

Basically, median patient was taking about 40 mg opioids a day. After a year, 15 mg Delta-9 thc and 15 mg CBD median dose of 15 mg of CBD, the team “significantly” has reduced 2.7 mg of opioid doses per day. After a year, the opioid was only taking a median 42.3 mg per day.

“The introduction of cannabinoids can create useful reductions of opioid consumer settings in the real world, with additional benefits for disability and insomnia,” Authors of study celurbill. “However, this treatment is only subjected by a sub-group of patients.”

In the Kannabis treatment regiment between the cohort, “the opioid consumption has significantly reduced in 6 to 12 months.”

“Physical activity and sleep also improved. These findings indicate that medicinal cannabis can help patients reduce their opioid activity and improve their physical activity and sleep.

The findings are also consistent with the body of scientific literature, exploring the association between the use of cannabis and opioids.

For example, a study published this year earlier found in drug and alcohol review, among drug users who experience chronic pain every day The use of cannabis was related to greater probability of leaving opioids-Species among men.

Also found a study posted last year Legalization of medical cannabis seemed to significantly reduce the monetary payments of opioids What specializes in pain, authors “declining that in terms of Marijuana doctor, proves that they are available as a replacement.

Last studies also showed the decline of operating operations, legalized by marijuana for adults in jurisdictions. This study found a “Coherent negative relationship between legalization and aggression” has more significant effects on the states that were legalized before the cannon In opium crisis. The authors computed the legalization of recreation marijuana “that 3.5 per person per person is linked to reduction.”

“Our discoveries suggest that you can help recreating access to leisure marijuana to deal with the opioid epidemic,” said the report. “Previous research represents that marijuana (especially doctors) can reduce the prescriptions of opioids, and that we find that overdose can also reduce deaths.”

Another newly published report according to the use of Opioid opioid after the state Marijuana doctor legalization The availability of the legal cannabis was found that both patients with chronic pain reduced the opioid use and helped reduce deaths exceeded by prescription. Overall, the results of the study indicated that “Cannabis has a key role to play in pain management and reduce the use of opioids,” he said.

Another study published in 2023, linked to medical marijuana Minor level of pain and reduced dependence on opioids and other prescription medications. And other February, another published by the American Medical Association (Mother), found chronic pains that received medical marijuana for more than a month viewed important reductions in prescribed opioids.

About Three chronic pain patients reported using cannabis As a treatment option, 2023 mothers published by a report. Most of that group said they used cannabis as another substitute for pain medicines, including opioids.

Other research published that year found that People buy CBD legally significantly reduced opioid prescription feesIt has less recipe for 6.6 and 8.1 percent.

About prescription drugs Medicaid analyzed a 2022 research paper, while he found the legalization of marijuana for adult use “Reduced relevant” prescription drug use To treat multiple conditions.

2023 Report Medical Marijuana Medical Legalization Related Medical Payments reducing doctors-You have other data activities when they use legal access to the prescription drugs that patients use cannabis as an alternative.

Researchers in another study published last year examined Oregon opioid prescription and mortality rates to find it Marijuana retail access by reducing the prescriptions of oversized opioidsAlthough they saw a decline in the decline of death related to opioids.

Last research also indicates that cannabis can be an effective replacement of heels in terms of pain management.

Report published in BMJ magazine, such as marijuana and opioids for chronic painless pain and Canavies found “can be similarly effective and may have fewer interruptions than opioids” Provide potentially comparable relief with a lower chance of harmful effects.

Published special studies found more than half patients with chronic musculoskeletal pain, which was more effective than other analgesic medications cannabis, and 40% reported Reducing the use of other anes in the use of marijuana.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

(Tagstotranslate) highlighted

Related Topics:
Continue Reading

Cannabis News

Bountiful Farms goes best in New England at NECANN Cup

Published

8 hours ago

on

May 25, 2026

By

Bountiful Farms placed first and second in the licensed solvent-free concentrate division at this year’s NECANN Cup, then also won the mixed licensed and unlicensed division to win best overall, putting the Massachusetts operator in the running for best in show with the highest-scoring product in New England.

© Bountiful Farms

NECANN is the largest B2B cannabis event in New England and the second largest in the country, attracting over 9,000 attendees. Everything is unbranded. Licensed and unlicensed operators in the six New England states compete only in product. Zachary Taylor, Director of Agriculture at Bountiful Farms, says the win for Maine’s craft growers means a lot to him and his team. “Whenever you compete against Maine, with its regulations and the craft culture of the caretakers, to be considered a craft on our scale is the greatest honor. When you look at cups across the nation, you see cups of culture, and Maine is always well represented. To be recognized on the same playing field and to excel at this scale is very difficult, and I don’t think that’s what people mean.”

Of course, rosin isn’t given more forcefully to Bountiful Farms. But Zach in a clean way© Bountiful Farms he says, “A good raisin doesn’t appear out of nowhere. It comes from the flower.” The award-winning genetics were bred by Crystal Rose, and built around a high-resin, terpene-rich expression.

“The buds come in within 15 minutes of harvest, it’s like a timer,” Zach says. “Then we move them to a chest freezer, before moving them to an aisle freezer, where they’ll sit until they’re cleaned. All the rosin is pressed by hand in a hydraulic press.” At its scale, Bountiful Farms must use automation to achieve consistently high quality. “But we have very practical components,” he said. “The backlash of the press tells you how hard it is to go. Same approach with agitation, for example. The flower heads themselves, how we maintain the integrity of the trichome, the rise time of the wash, the temperatures: everything is handled like a small-scale race.”

That level of attention comes from the team. Matt Bearup, now a solventless QC manager, started growing and built the hash lab from the ground up all by himself. There are currently eight hash makers, all passionate about complex genetics and terpenes. Strains include not only the main terpenes, but also tasting notes and effects. Using the SC Lab framework, limonene as the current focus. “There’s not a lot of that in the hashish sector in particular. Several growers are moving in that direction.”

© Bountiful Farms

“There’s not a lot like it. Several breeders are moving in that direction.”

Bountiful Farms has been producing rosin since 2021, when the category had little traction© Bountiful Farms in Massachusetts. Since then, the company has expanded into a high-end cultivation center to produce even more rosin. They operate two production rooms and processes not only for themselves, but also for other clients including Native Sun, Breathe Free and u4ea. They have recently opened two new dispensaries, allowing them to expand into recreational retail from 2021. Another limited release of the full melt is planned, along with a dual-cartridge solvent-free pen developed with O2 Vapes, two flavors in one device.

“When you bring award-winning companies together, you get products that represent the industry at its best. Massachusetts deserves its place among the leaders in this industry. When we win, the industry wins.”

For more information:
Prosperous Farms
prosperous farm. take care of

Continue Reading

Cannabis News

Federal Drug Testing Rule Will Require ‘Directly Observed’ Urine Collection From Truck Drivers

Published

9 hours ago

on

May 25, 2026

By

“A month that goes by without an oral fluid test is another month when federal employees with paruresis face anxiety, discrimination, and barriers.”

By Kastalia Medrano, Filter

The Department of Transportation will require “directly observed” urine drug testing in federal employment situations where saliva testing is required but not possible. The clarification of DOT drug and alcohol testing procedures is the latest development in a years-long push by the trucking industry. oral fluid testing as an alternative to urine testing.

The new rule was published in the Federal Register on May 11, and will go into effect on June 10.

Truck drivers, who are subject to a large number of federal regulations, do not choose the method of drug testing, while DOT-regulated employers do. The campaign to implement oral fluid testing has been led by the American Trucking Association (ATA), which believes it is necessary to “keep drivers with disabilities off the road and maintain the trucking industry’s commitment to safety.”

The Substance Abuse and Mental Health Services Administration (SAMHSA) approved lab-based oral fluid testing in 2019, and the DOT finalized its regulations in 2023 allowing employers to choose this as an alternative to urine testing. But the actual implementation requires at least. Two laboratories approved by the Food and Drug Administration to process tests—one for the initial analysis and another to confirm the results. There are currently zero.

Oral fluid testing is attractive to many employers for a number of reasons, one of which is its effectiveness in detecting drug use within hours compared to urine drug testing. While the trucking industry has become the public face of the campaign, the regulations also affect federal workers in the commercial aviation, railroad, public transportation and pipeline sectors.

One of the main concerns expressed by the trucking industry has been that urine drug screens are not visible, making it easier to avoid oral fluid testing. Another concern is paruresis, commonly referred to as “shy bladder” syndrome: if a driver can’t urinate when they need to, they’re stuck for a three-hour wait, which obviously affects their arrival time. And if they still cannot produce urine during this period, they are considered to have refused to take the test and are removed from their duties. To return, they must “pass” a urine test watched by a same-sex observer.

New DOT the rule also updates existing terminology by replacing the word “gender” with the word “sex” in accordance with President Donald Trump’s January 2025 executive order “Defending Women from Gender Ideological Extremism and Restoring Biological Truth to the Federal Government.”

“A month that goes without an oral fluid test is another month when federal employees with paruresis face anxiety, discrimination and professional barriers,” Dr. Steven Soifer, co-founder of the International Paruresis Society, said in March. “We have been working on this issue since our inception (30 years ago). Our members ask the same question every day: When will the federal government finish the work it has already approved?”

In April, at the request of ATA, six members of Congress he wrote Robert F. Kennedy Jr. to the Secretary of the Department of Health and Human Services citing FDA regulatory hurdles as the reason why laboratories in the United States are not certified to process oral fluid tests.

They cited an analysis by Quest Diagnostics that showed a 370 percent increase in “replaced” urine specimens from 2022 to 2023. Quest has its own laboratory-based oral fluid collection method, Quantisal™, and has therefore been an ardent supporter of the campaign.

On May 1, the FDA a notice with the intention of considering revising the requirements for toxicology studies. That same day SAMHSA a the list It confirms that currently certified laboratories, which will probably be updated in the future, but are not available at the moment.

However, at the end of the day, HHS handles oral fluid testing in a similar scenario to hair follicle testing. The department promised to create guidelines for hair testing in 2015, but has yet to do so.

This the article originally posted by The filteran online magazine that deals with drug use, drug policy and human rights from a harm reduction perspective. Follow Filter on Bluesky, X or Facebookand sign up for their newsletter.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Continue Reading

Cannabis News

TSA clarifies that cannabis policy has not changed

Published

1 day ago

on

May 24, 2026

By











Over the past week, many news organizations have been running exaggerated headlines about a supposed change by the federal government to allow marijuana to be brought into airports and airplanes. But it’s not true, the Transportation Security Administration (TSA) tells Marijuana Moment.

“TSA’s policy on medical marijuana has not changed,” a TSA spokeswoman said in an email Wednesday.

“According to the TSA website: If any illegal substance or evidence of criminal activity is found during the security screening, TSA will refer the matter to law enforcement,” they said. While it’s true that the agency’s list of medical marijuana “What can I bring?” section of its website was updated on April 27, there were no major changes in policy.

Currently, the website says “Yes,” passengers can carry medical marijuana in carry-on and checked bags with special instructions. But the TSA cannabis policy has said “Yes” to medical marijuana, with the same caveats, since 2019.

Read more at Marijuana Moment










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media